A Prospective, Randomized and Multi-center Clinical Study to Evaluate Efficacy and Safety of Combination Therapy of Mitiglinide or Voglibose With Long-acting Insulin in Type 2 Diabetic Patients.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Mitiglinide (Primary) ; Insulin glargine; Voglibose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GLORIA
- Sponsors JW Pharmaceutical
- 31 Aug 2018 Biomarkers information updated
- 29 Mar 2012 Company added in association field as reported by ClinicalTrials.gov.
- 18 Oct 2010 Actual end date (September 2009) added as reported by ClinicalTrials.gov.